Rhythm Pharmaceuticals Inc —— 季度现金流量表 (NASDAQ:RYTM) | MetaTrader

展开完整图表

Financials

概览声明统计

每季度年度

总资产 392.27 M386.69 M372.73 M506.87 M480.2 M 负债总额 227.72 M223.6 M239.15 M211.19 M210.17 M 权益总额 21.73 M18.95 M-11.91 M148.82 M139.07 M 负债及股东权益总额 392.27 M386.69 M372.73 M506.87 M480.2 M 总债务 109.81 M109.52 M109.79 M108.97 M108.18 M 净债务 -210.75 M-204.96 M-181.21 M-307.13 M-280.72 M

新闻

Strength Seen in Rhythm Pharmaceuticals (RYTM): Can Its 12.6% Jump Turn into More Strength?

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity - Slideshow (NASDAQ:RYTM) 2026-03-24

Rhythm Surges On A New Obesity Approval; How It Edged In Where Lilly, Novo 'Have Fallen Flat'

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses FDA Approval of IMCIVREE for Acquired Hypothalamic Obesity Transcript

Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)

Rhythm Pharmaceuticals Misses The Beat In Obesity, But There's A Caveat

Needham因试验失败下调Rhythm Pharmaceuticals目标价

Needham cuts Rhythm Pharmaceuticals stock price target on trial miss

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial - Slideshow (NASDAQ:RYTM) 2026-03-17

Rhythm Pharmaceuticals, Inc. (RYTM) Discusses Topline Results and Insights from Phase 3 EMANATE Trial Transcript

Rhythm Pharma shares fall as obesity drug trial fails to meet main goal

Stifel重申Rhythm Pharmaceuticals股票评级为买入